GlassScriptPhysician profile
Niger K Stice
NPI 1548500770
$508.54
in general payments reported to CMS, 2019-2025
11 companies · $29.29 in 2025
The $29.29 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $85.43 · 2022: $266 · 2023: $91.99 · 2024: $35.65 · 2025: $29.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $156.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $283.65 | 2022-2023 | |
| Baudax Bio INC. | $57.10 | 2021-2022 | |
| Spr Therapeutics, INC | $35.65 | 2024 | Sprint Pns System |
| Abbott Laboratories | $29.29 | 2025 | Navitor |
| Orexo US, INC. | $21.36 | 2021 | |
| Nalu Medical, INC. | $18.47 | 2023 | Nalu Neurostimulation System |
| Collegium Pharmaceutical, INC. | $15.58 | 2022 | |
| Midsouth Orthopedics INC. | $14.78 | 2022 | |
| Biodelivery Sciences International, INC. | $12.36 | 2021 | |
| Pfizer INC. | $12.04 | 2021 | |
| Stimwave Technologies Incorporated | $8.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niger Stice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.